Results 291 to 300 of about 51,921 (307)

Severe eosinophilic asthma

European respiratory journal, 2017
Buhl, Roland, Humbert, Marc, Bjermer, Leif, Chanez, Pascal, Heaney, Liam G., Pavord, Ian, Quirce, Santiago, Virchow, Johann C., Holgate, Stephen, Djukanovic, Ratko, Chung, Kian Fan, Canonica, Walter, Papi, Alberto, Brightling, Chris, Horváth, Ildiko, Walker, Samantha, Brusselle, Guy, Backer, Vibeke, Kuna, Piotr, Bel, Elisabeth, De Llano, Luis Perez, Rabe, Klaus   +21 more
openaire   +1 more source

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Lancet Respiratory Medicine,the, 2017
Frank C Albers, Linda M Nelsen, Jennifer L Trevor   +2 more
exaly  

Mast-Cell Infiltration of Airway Smooth Muscle in Asthma

New England Journal of Medicine, 2002
Christopher E Brightling, Peter Bradding, Andrew J Wardlaw   +2 more
exaly  

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

Lancet Respiratory Medicine,the, 2014
Mario Castro, Eugene R Bleecker, Emilio Pizzichini   +2 more
exaly  

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

Lancet Respiratory Medicine,the, 2016
Sherif Gonem, Rachid Berair, Salman Siddiqui Frcp   +2 more
exaly  

Reslizumab for Poorly Controlled, Eosinophilic Asthma

American Journal of Respiratory and Critical Care Medicine, 2011
Mario Castro, Sameer K Mathur, Parameswaran Nair   +2 more
exaly  

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

New England Journal of Medicine, 2009
Parameswaran Nair, Melanie Kjarsgaard, Emilio Pizzichini   +2 more
exaly  

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

Lancet Respiratory Medicine,the, 2016
Steven W Yancey, Necdet B Gunsoy, Oliver N Keene   +2 more
exaly  

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

Lancet, The
Brian D Kent
exaly  

Severe eosinophilic asthma and mepolizumab

The Lancet Respiratory Medicine, 2016
openaire   +2 more sources